[1]
P. R. Obreli Neto, “Effect of a 36-month Pharmaceutical Care Program on the Coronary Heart Disease Risk in Elderly Diabetic and Hypertensive Patients”, J Pharm Pharm Sci, vol. 14, no. 2, pp. 249–263, Jun. 2011.